News Announcement

Mankind Pharma: Outcome Of Board Meeting

The Board at its meeting held on 02nd August 2023 has inter alia approved the following:1. Re-appointment of Mr. Ramesh Juneja as Chairman and Whole Time Director.2. Re-appointment of Mr. Rajeev Juneja as Vice Chairman and Managing Director.3. Re-appointment of Mr. Sheetal Arora as Whole-time Director and Chief Executive Officer.4. Re-designation of Mr. Suresh Raju Penmetsa as Chief Risk Officer and Vice President EHS.5. Re-appointment of M/s Dayal & Maur Company Secretaries as the Secretarial Auditor of the Company for the FY 2023-24.6. Ratification of Mankind Employee Stock Option Plan 2022.7. Ratification of grant of employee stock option to the employees of subsidiary company(ies)/Group Company/ Associate Companies.Item no. 1 2 3 6 and 7 are subject to approval of the members of the Company.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.